These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer. Mei H; Lian S; Zhang S; Wang W; Mao Q; Wang H Biochem Biophys Res Commun; 2014 Oct; 453(4):703-9. PubMed ID: 25301559 [TBL] [Abstract][Full Text] [Related]
27. High expression of MAGE-A9 is associated with unfavorable survival in esophageal squamous cell carcinoma. Qi Y; Cao KX; Xing FC; Zhang CY; Huang Q; Wu K; Wen FB; Zhao S; Li X Oncol Lett; 2017 Sep; 14(3):3415-3420. PubMed ID: 28927095 [TBL] [Abstract][Full Text] [Related]
28. Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans. Park MS; Park JW; Jeon CH; Lee KD; Chang HK J Korean Med Sci; 2002 Aug; 17(4):497-501. PubMed ID: 12172045 [TBL] [Abstract][Full Text] [Related]
29. Expression of MAGE-A1, -A9, -A11 in laryngeal squamous cell carcinoma and their prognostic significance: a retrospective clinical study. Liu S; Sang M; Xu Y; Gu L; Liu F; Shan B Acta Otolaryngol; 2016; 136(5):506-13. PubMed ID: 26766421 [TBL] [Abstract][Full Text] [Related]
30. Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy. Deng W; Jiao N; Li N; Wan X; Luo S; Zhang Y Biomed Pharmacother; 2015 Jul; 73():1-5. PubMed ID: 26211574 [TBL] [Abstract][Full Text] [Related]
31. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer. Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852 [TBL] [Abstract][Full Text] [Related]
32. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma. Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S Oncology; 2009; 77(1):53-62. PubMed ID: 19556810 [TBL] [Abstract][Full Text] [Related]
33. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma. Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544 [TBL] [Abstract][Full Text] [Related]
35. Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer. Luo Y; Qin SL; Mu YF; Wang ZS; Zhong M; Bian ZQ Biomed Pharmacother; 2015 Jul; 73():135-9. PubMed ID: 26211594 [TBL] [Abstract][Full Text] [Related]
36. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer. Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935 [TBL] [Abstract][Full Text] [Related]
37. Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma. Niu Y; Wang L; Cheng C; Du C; Lu X; Wang G; Liu J APMIS; 2015 Feb; 123(2):93-101. PubMed ID: 25257341 [TBL] [Abstract][Full Text] [Related]
38. Expression of family A melanoma antigen in human gastric carcinoma. Jung EJ; Kim MA; Lee HS; Yang HK; Lee YM; Lee BL; Kim WH Anticancer Res; 2005; 25(3B):2105-11. PubMed ID: 16158951 [TBL] [Abstract][Full Text] [Related]
39. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk. Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797 [TBL] [Abstract][Full Text] [Related]
40. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance. He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]